276 related articles for article (PubMed ID: 17471597)
41. What happened to patients with behavioural and psychological symptoms of dementia (BPSD) after the Committee on Safety in Medicines (CSM) guidelines?
Raju J; Sikdar S; Krishna T
Int J Geriatr Psychiatry; 2005 Sep; 20(9):898-9. PubMed ID: 16116573
[No Abstract] [Full Text] [Related]
42. Cerebrovascular events after treatment of dementia patients with risperidone.
Wancata J
Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366
[No Abstract] [Full Text] [Related]
43. [Effectiveness of typical and atypical neuroleptics in the control of behavioral and psychopathological symptoms of dementia. Results of a retrospective study].
Martin Carrasco M; Ballesteros J; Bulbena A; Baraibar G; García C; Minguez L; Blanco J; de Blas J; Agüero JA; Ibarra N
Actas Esp Psiquiatr; 2006; 34(4):251-6. PubMed ID: 16823686
[TBL] [Abstract][Full Text] [Related]
44. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.
Lee PE; Gill SS; Freedman M; Bronskill SE; Hillmer MP; Rochon PA
BMJ; 2004 Jul; 329(7457):75. PubMed ID: 15194601
[TBL] [Abstract][Full Text] [Related]
45. Interpatient variations in antipsychotic therapy.
McIntyre IM; Gershon S
J Clin Psychiatry; 1985 May; 46(5 Pt 2):3-5. PubMed ID: 2859279
[TBL] [Abstract][Full Text] [Related]
46. [Anesthesia for cesarean section in a parturient taking risperidone and haloperidol].
Kato R; Sato J; Suzuki H
Masui; 2005 Mar; 54(3):301-3. PubMed ID: 15794111
[TBL] [Abstract][Full Text] [Related]
47. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
Barr AM; Honer WG; Johnson JL; Wu TK; Procyshyn RM
J Clin Psychopharmacol; 2010 Dec; 30(6):741-3. PubMed ID: 21057241
[No Abstract] [Full Text] [Related]
48. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
[TBL] [Abstract][Full Text] [Related]
49. [Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].
Ruths S; Straand J
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1672-5. PubMed ID: 15976839
[TBL] [Abstract][Full Text] [Related]
50. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
51. Risperidone treatment of an adolescent with severe posttraumatic stress disorder.
Keeshin BR; Strawn JR
Ann Pharmacother; 2009 Jul; 43(7):1374. PubMed ID: 19584378
[No Abstract] [Full Text] [Related]
52. Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home.
Suh GH; Shah A
Int Psychogeriatr; 2005 Sep; 17(3):429-41. PubMed ID: 16252375
[TBL] [Abstract][Full Text] [Related]
53. Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.
Chen ZH; Wang GH; Wang XP; Chen RY; Wang HL; Yang MH; Huo YX; Mei HB
Hum Psychopharmacol; 2008 Aug; 23(6):465-70. PubMed ID: 18536066
[TBL] [Abstract][Full Text] [Related]
54. How safe are antipsychotics in dementia?
BMJ Group
Drug Ther Bull; 2007 Nov; 45(11):81-5. PubMed ID: 18165678
[TBL] [Abstract][Full Text] [Related]
55. Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent.
Prescrire Int; 2007 Dec; 16(92):236-7. PubMed ID: 18092400
[TBL] [Abstract][Full Text] [Related]
56. Recommended haloperidol and risperidone doses in first-episode psychosis.
McGorry PD
J Clin Psychiatry; 1999 Nov; 60(11):794-5. PubMed ID: 10584773
[No Abstract] [Full Text] [Related]
57. Reader response to, "Effects of risperidone on aberrant behavior in persons with developmental disabilities: I. A double-blind crossover study using multiple measures".
Levitas A
Am J Ment Retard; 2003 May; 108(3):212-4; author reply 214-6. PubMed ID: 12691600
[No Abstract] [Full Text] [Related]
58. Risperidone for insomnia in PDDs.
Doan RJ
Can J Psychiatry; 1998 Dec; 43(10):1050-1. PubMed ID: 9868572
[No Abstract] [Full Text] [Related]
59. [Neuroleptic malignant syndrome in users of risperidone].
Kroon JG
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
[No Abstract] [Full Text] [Related]
60. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients.
Chan WC; Lam LC; Choy CN; Leung VP; Li SW; Chiu HF
Int J Geriatr Psychiatry; 2001 Dec; 16(12):1156-62. PubMed ID: 11748775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
